%0 Journal Article %T Urinary UBC Rapid and NMP22 Test for Bladder Cancer Surveillance in Comparison to Urinary Cytology: Results from a Prospective Single-Center Study %A Gennadi Tulchiner %A Georg Schaefer %A Isabel Heidegger %A Josef Fritz %A Renate Pichler %A Wolfgang Horninger %J International Journal of Medical Sciences %D 2017 %R 10.7150/ijms.19929 %X Background: Non-muscle invasive bladder cancer (NMIBC) is associated with high rates of recurrence, resulting in frequent follow-up cystoscopies. We evaluated the use of two point-of-care tests - the nuclear matrix protein 22 (NMP22) and urinary bladder cancer antigen (UBC) Rapid - compared to routine follow-up in patients with a previous history of NMIBC. %K Bladder Cancer %K surveillance %K recurrence %K urine markers %K cytology %K NMP22 %K UBC %K biomarkers %U http://www.medsci.org/v14p0811.htm